DMC and Conagen partner for commercial manufacturing of L-alanine

News
- 22/04/2021

Boulder, CO, USA: 21 April 2021 – DMC Biotechnologies and Conagen Inc. have entered into a manufacturing agreement for the commercial production of DMC’s first product, L-alanine.

L-alanine is a naturally occurring amino acid used widely in homecare products, human nutrition, and pharmaceutical applications. DMC’s fermentation technology enables L-alanine to be produced with attractive economics as part of a regional supply chain with increased reliability and greater sustainability.

This partnership combines Conagen’s production expertise with DMC’s bioprocess technology and follows DMC’s demonstration of commercial-scale production (85m3) in March 2021. DMC has a robust product pipeline, including additional amino acids, that will subsequently be brought to the market.

More information on DMC’s website.